Oprea-Lager Daniela E, Kramer Gem, van de Ven Peter M, van den Eertwegh Alfons J M, van Moorselaar Reindert J A, Schober Patrick, Hoekstra Otto S, Lammertsma Adriaan A, Boellaard Ronald
Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands.
J Nucl Med. 2016 May;57(5):721-7. doi: 10.2967/jnumed.115.167692. Epub 2015 Dec 23.
Repeatable quantification is essential when using (18)F-fluoromethylcholine PET/CT to monitor treatment response in prostate cancer. It has been shown that SUV normalized to the area under the blood activity concentration curve (SUVAUC) provides a better correlation with full kinetic analysis than does standard SUV. However, the precision of SUVAUC is not known yet. The purpose of this study was to assess the repeatability of various semiquantitative (18)F-fluoromethylcholine parameters in prostate cancer.
Twelve patients (mean age ± SD, 64 ± 8 y) with metastasized prostate cancer underwent two sets of (18)F-fluoromethylcholine PET/CT scans, on consecutive days. Each set consisted of a 30-min dynamic PET/CT scan of the chest after intravenous administration of 200 MBq of (18)F-fluoromethylcholine, followed by a whole-body PET/CT scan at 40 min. The dynamic scan was used to derive the area under the blood activity concentration curve. Lesion uptake was derived from the whole-body scan using various types of volumes of interest: maximum, peak, and mean. Each of these parameters was normalized to injected activity per body weight, area under the blood activity concentration curve, and blood concentration itself at 40 min, resulting in several types of SUVs: SUV, SUVAUC, and SUVTBR The test-retest repeatability of these metrics, as well as metabolic tumor volume (MTV) and total uptake of choline in the lesion, were studied. The level of agreement between test-retest data and reliability was assessed using Bland-Altman plots, repeatability coefficients, and intraclass correlation coefficients (ICCs).
A total of 67 choline-avid metastases were identified: 44 bone lesions and 23 lymph node lesions. In the case of SUVmax, the repeatability coefficients for SUV, SUVAUC, and SUVTBR were 26% (ICC, 0.95), 31% (ICC, 0.95), and 46% (ICC, 0.89), respectively. Similar values were obtained for SUVpeak and SUVmean The repeatability of SUVAUC was comparable to that of SUVmax, SUVpeak, and SUVmean. Tissue type and tumor localization did not affect repeatability. An MTV of less than 4.2 cm(3) had larger variability than larger volumes (repeatability coefficient, 45% vs. 29%; P = 0.048). The repeatability coefficient did not significantly differ between lesions with SUVpeak above or below the median value of 8.3 (19% vs. 28%; P = 0.264).
The repeatability of SUVAUC was comparable to that of standard SUV. The repeatability coefficients of various semiquantitative (18)F-fluoromethylcholine parameters (SUV, MTV, and total uptake in the lesion) were approximately 35%. Larger differences are likely to represent treatment effects.
使用¹⁸F-氟甲基胆碱PET/CT监测前列腺癌的治疗反应时,可重复性定量至关重要。研究表明,与标准SUV相比,归一化至血药浓度曲线下面积的SUV(SUVAUC)与完整动力学分析的相关性更好。然而,SUVAUC的精密度尚不清楚。本研究的目的是评估前列腺癌中各种¹⁸F-氟甲基胆碱半定量参数的可重复性。
12例(平均年龄±标准差,64±8岁)转移性前列腺癌患者连续两天接受两组¹⁸F-氟甲基胆碱PET/CT扫描。每组扫描包括静脉注射200MBq¹⁸F-氟甲基胆碱后进行30分钟的胸部动态PET/CT扫描,随后在40分钟时进行全身PET/CT扫描。动态扫描用于得出血药浓度曲线下面积。病变摄取量通过全身扫描使用不同类型的感兴趣区得出:最大、峰值和均值。这些参数中的每一个均归一化至每体重注射活度、血药浓度曲线下面积以及40分钟时的血药浓度本身,从而得出几种类型的SUV:SUV、SUVAUC和SUVTBR。研究了这些指标以及代谢肿瘤体积(MTV)和病变中胆碱总摄取量的重测可重复性。使用Bland-Altman图、可重复性系数和组内相关系数(ICC)评估重测数据之间的一致性水平和可靠性。
共识别出67个胆碱摄取性转移灶:44个骨病变和23个淋巴结病变。对于SUVmax,SUV、SUVAUC和SUVTBR的可重复性系数分别为26%(ICC,0.95)、31%(ICC,0.95)和46%(ICC,0.89)。SUVpeak和SUVmean也获得了类似的值。SUVAUC的可重复性与SUVmax、SUVpeak和SUVmean相当。组织类型和肿瘤定位不影响可重复性。MTV小于4.2cm³的变异性大于较大体积者(可重复性系数,45%对29%;P = 0.048)。SUVpeak高于或低于中位数8.3的病变之间,可重复性系数无显著差异(19%对28%;P = 0.264)。
SUVAUC的可重复性与标准SUV相当。各种¹⁸F-氟甲基胆碱半定量参数(SUV、MTV和病变总摄取量)的可重复性系数约为35%。较大差异可能代表治疗效果。